dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Canon adds radiation oncology functioning to Aquilion CTs Can be shared between radiology and radiation oncology departments

Philips and MIM Software collab to streamline radiotherapy treatment planning Integrate portfolios of CT, MR and software solutions

ZAP Surgical launches radiosurgery platform for treating brain tumors Lowers cost of SRS with self-shielding technology

First Southeast Asian proton therapy center opens in India Will treat more than 3 million Indians with cancer, and other SE Asian populations

FDA clears MIM SurePlan molecular radiotherapy software Can measure the absorbed dose from MRT for individual patients

Addressing the radiation-related cancer risk of obese patients A complex problem and a call for better dose optimization

Mevion to install PT system at Mercy Hospital St. Louis Equipped with HYPERSCAN technology

GE and VUMC partner to make cancer immunotherapy safer and more precise Five-year collab will yield new AI apps and PET tracers

Proton therapy pioneer James M. Slater dies at 89 Oversaw creation of the world's first proton treatment center

UK and US researchers develop AI models for evaluating emotional burden of cancer More clearly assesses reduction in quality of life

ViewRay to supply UK's GenesisCare with country's first MRIdian systems

by John R. Fischer , Staff Reporter
ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new partnership between it and the cancer service provider, GenesisCare.

Deployed within the GenesisCare network, the first two systems will offer oncologists the ability to leverage soft-tissue imaging for the visualization of tumors, personalizing treatment with greater accuracy in the delivery of high-quality, image-guided, adaptive radiotherapy.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"Combining an MR scanner with a linear accelerator is the way of the future in radiotherapy, allowing us to see – for the first time – what's really happening inside the body during treatment,” Aldo Rolfo, executive manager for GenesisCare Europe, said in a statement. “This will enable our clinicians to offer truly personalized radiotherapy by adapting treatment in real time, to better target tumors and minimize side effects for patients."

The system integrates MR technology, radiation delivery, and proprietary software to locate, target and track the position and shape of tumors while radiation is delivered, with its application of MR guidance reducing uncertainty involved in treatment.

Installation of the solution follows an earlier installation and commissioning this year at the University Clinic Heidelberg in Germany, as well as the awarding of a tender for installation at Centre Georges-François Leclerc in France.

In addition, the system is now equipped with MR pulse sequencing, higher image resolution, improvement in MR noise-to-signal ratio; and the integration of diffusion-weighted imaging, features showcased earlier this year at ESTRO 2018 in Barcelona, Spain.

Comprising more than 2,500 healthcare professionals and supporting staff members, GenesisCare delivers radiotherapy to more than 160,000 patients annually at 12 centers throughout the U.K., 21 in Spain and 30 in Australia.

"The reach of the GenesisCare network is vast and their investment in MRIdian is a testament to its industry-leading innovation for on-table adaptive therapy,” Scott Drake, president and CEO of ViewRay, said in a statement. “We are proud to be revolutionizing the field of radiation oncology."

News of MRIdian’s arrival has already been met with warm welcomes and cheers from Britain’s radiology community. #ViewRay MRIdian will be the focus of a new network of experienced #SABR clinicians and treatment teams, dedicated to bringing top flight IGRT and clinical trials to more patients,” tweeted cancer consultant specialist and oncologist Dr. James Good of Queen Elizabeth Hospital in Birmingham. “Delighted to be part of this effort…”

The system was cleared by the FDA in 2012 and CE marked in 2014.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED